Benign Prostate Hyperplasia | sciencenewsnet.in

Breaking News

Daniel B.F. Saris, MD, PhD, Receives the First Arnold I. Caplan Award for Distinguished Research in Orthobiologics

Wildfire smoke can carry toxins hundreds of kilometres, depositing grime on urban structures, surfaces: research

Los Alamos National Laboratory partners with OpenAI to advance national security

Friedman School Receives Historic $10 Million Gift for Financial Aid

Astronomers Detect Missing Ingredient in Cooking Up Stars

Researchers examine economic impacts of aquatic dead zones

UA Little Rock Awarded $750,000 Cybersecurity Training Grant

Happiness expert available: Case Western Reserve University researcher gives tips for how to build resilience, motivation and well-being in a time of crisis

MyOme and Novi Health Collaborate to Bring Whole Genome Testing to Employer Health Programs

Grossman wins 2025 Transatlantic Alliance Award in Endocrinology

30 Jan, 2025

The Mount Sinai Hospital Becomes First in NYC to Offer Advanced HYDROS™ Robotic System for Treating Enlarged Prostates

January 27, 2025 sarah JonasAnnouncement

The Mount Sinai Hospital has performed New York City’s first procedure using the HYDROS™ Robotic System, a cutting-edge technology designed to treat benign prostatic hyperplasia (BPH), or an enlarged prostate. The minimally invasive procedure offers new hope for patients experiencing the symptoms of BPH, including frequent urination, incomplete bladder emptying, and nighttime urgency. Urologists at the hospital recently performed the health system’s first three procedures, with all patients responding well to the treatment and being discharged the following day.